Surgery Partners Company Insiders

SGRY Stock  USD 23.35  0.84  3.73%   
Surgery Partners' insiders are aggressively selling. The analysis of insiders' sentiment of trading Surgery Partners stock suggests that vertually all insiders are panicking at this time. Surgery Partners employs about 10.5 K people. The company is managed by 16 executives with a total tenure of roughly 27 years, averaging almost 1.0 years of service per executive, having 656.25 employees per reported executive.
Wayne DeVeydt  Chairman
Executive Chairman
Jennifer Baldock  President
Senior Vice President General Counsel, Secretary

Surgery Partners' Insider Buying Vs Selling

0

 
Selling
 
Buying

Latest Trades

2024-06-12Danielle BurkhalterDisposed 6000 @ 26.39View
2024-05-31Bradley R OwensDisposed 6000 @ 27.65View
2024-03-13Jason Eric EvansDisposed 4840 @ 29.71View
2024-03-11Jason Eric EvansDisposed 1984 @ 29.44View
2024-02-12Jason Eric EvansDisposed 5780 @ 35.08View
2024-02-06Danielle BurkhalterDisposed 167 @ 32.24View
2024-02-02Marissa BrittenhamDisposed 1637 @ 31.89View
2023-12-19Andrew T KaplanDisposed 7826870 @ 33.44View
Monitoring Surgery Partners' insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Surgery Partners. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
For more information on how to buy Surgery Stock please use our How to Invest in Surgery Partners guide.

Surgery Partners' Workforce Through the Years

Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Surgery Partners' future performance. Based on our forecasts, it is anticipated that Surgery will maintain a workforce of slightly above 10500 employees by December 2024.
 
Yuan Drop
 
Covid

Surgery Partners Management Team Effectiveness

The company has return on total asset (ROA) of 0.039 % which means that it generated a profit of $0.039 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0308 %, meaning that it created $0.0308 on every $100 dollars invested by stockholders. Surgery Partners' management efficiency ratios could be used to measure how well Surgery Partners manages its routine affairs as well as how well it operates its assets and liabilities. Return On Capital Employed is likely to rise to 0.07 in 2024, whereas Return On Tangible Assets are likely to drop (0.01) in 2024. At this time, Surgery Partners' Non Currrent Assets Other are fairly stable compared to the past year. Intangibles To Total Assets is likely to rise to 0.76 in 2024, whereas Total Assets are likely to drop slightly above 4.6 B in 2024.
Common Stock Shares Outstanding is likely to rise to about 131.9 M in 2024, whereas Net Loss is likely to drop (51.6 M) in 2024.

Surgery Partners Workforce Comparison

Surgery Partners is rated below average in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 280,631. Surgery Partners holds roughly 10,500 in number of employees claiming about 4% of equities under Health Care industry.

Surgery Partners Profit Margins

The company has Profit Margin (PM) of (0.02) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 0.13 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.13.
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.30.193
Way Up
Slightly volatile
Operating Profit Margin0.150.1196
Significantly Up
Slightly volatile

Surgery Partners Insider Trading History

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Surgery Partners insiders, such as employees or executives, is commonly permitted as long as it does not rely on Surgery Partners' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Surgery Partners insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Yuan Drop
 
Covid
Buy/Sell Ratio# Purchases Trades# Sales TradesTotal Shares PurchasedTotal Shares Sold
2024-09-01
1.0
2
2
 3,128 
 6,325 
2024-06-01
2.5
5
2
 30,850 
 12,000 
2024-03-01
0.4
12
30
 151,052 
 53,383 
2023-12-01
0.0769
1
13
 100,000 
 33,512,743 
2023-06-01
1.6667
5
3
 20,960 
 28,082 
2023-03-01
0.4286
15
35
 277,401 
 125,093 
2022-12-01
5.0
5
1
 27,581,019 
 4,338 
2022-06-01
0.5556
5
9
 20,150 
 129,414 
2022-03-01
0.4706
16
34
 178,753 
 194,009 
2021-09-01
0.5
1
2
 2,000 
 184.00 
2021-06-01
0.1667
2
12
 45,217,850 
 814,279 
2021-03-01
1.069
31
29
 404,758 
 94,583 
2020-12-01
0.1111
1
9
 4,199 
 16,274 
2020-03-01
2.75
11
4
 503,785 
 11,915 
2019-09-01
1.0
3
3
 51,000 
 115,423 
2019-06-01
3.0
6
2
 647,923 
 9,063 
2019-03-01
1.2778
23
18
 1,962,079 
 29,616 
2018-12-01
1.0
5
5
 208,169 
 201,991 
2018-09-01
2.0
4
2
 31,460 
 19,789 
2018-06-01
0.25
1
4
 14,749 
 0.00 
2018-03-01
2.0
8
4
 882,077 
 3,621 
2017-12-01
0.25
1
4
 67,264 
 2,846 
2017-03-01
2.0
10
5
 117,433 
 11,580 
2016-09-01
2.0
2
1
 22,024 
 2,500 
2015-12-01
0.3333
1
3
 4,015 
 1,477,430 
2015-09-01
0.1667
1
6
 4,473 
 0.00 

Surgery Partners Notable Stakeholders

A Surgery Partners stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Surgery Partners often face trade-offs trying to please all of them. Surgery Partners' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Surgery Partners' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Wayne DeVeydtExecutive ChairmanProfile
Bradley OwensPresident GroupProfile
Harrison BanePresident GroupProfile
Jennifer BaldockSenior Vice President General Counsel, SecretaryProfile
Eric EvansCOO, Executive Vice PresidentProfile
Anthony TaparoPresident - Atlantic GroupProfile
David DohertyExecutive CFOProfile
David CPAExecutive CFOProfile
Spencer ClarkGeneral VPProfile
Danielle BurkhalterExecutive OfficerProfile
Jennifer JDExecutive OfficerProfile
Roxanne WomackSenior OfficerProfile
Neil ZieselmanSenior ControllerProfile
Kristi JensenSenior RegionProfile
Marissa BrittenhamExecutive OfficerProfile
Varun GadhokSenior OfficerProfile

About Surgery Partners Management Performance

The success or failure of an entity such as Surgery Partners often depends on how effective the management is. Surgery Partners management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Surgery management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Surgery management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Tangible Assets 0.00 (0.01)
Return On Capital Employed 0.05  0.07 
Return On Equity(0.01)(0.01)
Please note, the imprecision that can be found in Surgery Partners' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Surgery Partners. Check Surgery Partners' Beneish M Score to see the likelihood of Surgery Partners' management manipulating its earnings.

Surgery Partners Workforce Analysis

Traditionally, organizations such as Surgery Partners use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Surgery Partners within its industry.

Surgery Partners Manpower Efficiency

Return on Surgery Partners Manpower

Revenue Per Employee261.3K
Revenue Per Executive171.5M
Net Loss Per Employee1.1K
Net Loss Per Executive743.8K
Working Capital Per Employee35.4K
Working Capital Per Executive23.2M

Additional Tools for Surgery Stock Analysis

When running Surgery Partners' price analysis, check to measure Surgery Partners' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Surgery Partners is operating at the current time. Most of Surgery Partners' value examination focuses on studying past and present price action to predict the probability of Surgery Partners' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Surgery Partners' price. Additionally, you may evaluate how the addition of Surgery Partners to your portfolios can decrease your overall portfolio volatility.